SUBSCRIBE
SUBSCRIBE
News   Policy

U.S. FDA Warns Glenmark Pharmaceuticals on Unapproved Drug

March 17, 2010 | 
1 min read
Reuters -- Glenmark Pharmaceuticals Ltd (GLEN.BO) sold nitroglycerin tablets without approval from U.S. regulators, the Food and Drug Administration said in a letter released on Tuesday.
Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
The white plane flies against the blue sky, leaving a white trail. Vector illustration
Vaccines
ACIP Meeting Delayed as Turbulence Rocks CDC, US Vaccine Policy
February 20, 2026
 · 
2 min read
 · 
Tristan Manalac
Man hand with magnifying glass. Yellow ray coming from loupe. Conducting check, information search and analysis concept. Spy, accountant, auditor job in abstract style. High quality photo
Regulatory
FDA’s Top Drug Regulator To Probe Safety of Antidepressants, RSV Antibodies
February 20, 2026
 · 
2 min read
 · 
Tristan Manalac
Black box mockup for cosmetics, perfume, presentation with shadows, isolated on background. Product photo for advertising package. Template for stylish cardboard packaging for goods.
Government
Cassidy Names Areas of Improvement for FDA’s Regulatory ‘Black Box’
February 19, 2026
 · 
3 min read
 · 
Tristan Manalac
Document checking, agreement or contract validation, financial or budget analysis, search for document files concept, businessman manager holding big magnifying glass checking document paper.
Regulatory
It’s Official: FDA Will Now Default to One Clinical Trial for Drug Applications
February 19, 2026
 · 
3 min read
 · 
Tristan Manalac